Ledger.Open graph →

SEC Form D · filed October 11, 2018

Mid-Atlantic BioTherapeutics, Inc

Offering

$10.0M

Sold

$875K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DOYLESTOWN, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

David Horn · Doylestown, PAExec · Director David Jobes · Doylestown, PAExec · Director Jean Pierre Gagnon · Doylestown, PAExec · Director Zach Sadek · Boston, MAExec · Director Kurt Brumme · Boston, MAExec · Director David Ament · Boston, MAExec · Director Dil P. Dhungyel · Fort worth, TXExec · Director Tika P. Dhungyel · Fort Worth, TXExec · Director Madhav D. Ghimire · Fort Worth, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗